| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $34.2B | $35.4B | $34.2B | — | $27.1B | $6.8B | $7.0B | $6.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | $1.6B | $1.4B | $1.3B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.7B | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | $3.5B | $2.8B | $2.5B |
| Net Income | $2.1B | $3.9B | $3.9B | $4.6B | $4.4B | $0.9B | $0.7B | $0.8B |
| EPS (Basic) | $7.98 | $14.31 | $13.73 | $15.74 | $14.28 | $2.82 | $2.13 | $2.42 |
| EPS (Diluted) | — | $14.31 | $13.73 | $15.72 | $14.27 | $2.82 | $2.13 | $2.42 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $34.4B | $41.3B | $39.2B | $38.0B | $33.2B | $29.9B | $29.4B | $28.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $3.8B | — | — | — | — | $2.9B | — | $1.6B |
| Total Liabilities | $12.3B | $13.3B | $12.5B | $13.7B | $12.2B | $11.8B | $13.3B | $13.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $22.0B | $27.9B | $26.6B | $24.1B | $20.8B | $18.0B | $15.9B | $14.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $2.4B | $5.2B | $3.3B | $2.5B | $4.2B | $1.5B | $1.7B |
| Investing Cash Flow | $0.2B | $-0.3B | $-0.2B | $-0.1B | $-0.1B | $-0.3B | $0.0B | $-0.6B |
| Capital Expenditures | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $-1.6B | $-3.7B | $-3.2B | $-1.3B | $-2.4B | $-2.4B | $-1.6B | $-2.2B |